Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1895 results

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

US02-07-2020Rory O'Neill

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Labrador drops BioFire suit after COVID-19 revelation


Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

J&J wants $25m over ‘contaminated’ fake medical tools


Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.

Latham recruits two from Hogan Lovells


Latham & Watkins has added two life sciences-focused litigators, Arlene Chow and Ernest Yakob, to its New York office.

Gilead expands oncology business with Pionyr deal

US25-06-2020Mergers & acquisitions

Gilead Sciences has begun a potential takeover of Pionyr Immunotherapeutics after it agreed to pay $275 million for a 49.9% equity stake in the cancer research company.

3M secures settlements in price-gouging litigation

US23-06-2020Sarah Morgan

3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic.

Mylan scores multiple sclerosis patent win over Biogen


Mylan has succeeded in having a key Biogen patent covering multiple sclerosis drug Tecfidera invalidated by a US federal court.

Roche accuses competitor of infringing diabetes patent

Switzerland, US22-06-2020Sarah Morgan

Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor. 

MicroPort accuses rival of selling ‘knock-off’ surgical tools


MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.

Illumina secures injunction against BGI

US18-06-2020Sarah Morgan

Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.

Showing 1 to 10 of 1895 results